0000899243-20-030838.txt : 20201112 0000899243-20-030838.hdr.sgml : 20201112 20201112170626 ACCESSION NUMBER: 0000899243-20-030838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201109 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RODEN MATTHEW CENTRAL INDEX KEY: 0001828130 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 201307875 MAIL ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-09 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001828130 RODEN MATTHEW C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 26.35 2020-11-09 4 A 0 33217 0.00 A 2030-11-09 Common Stock 33217 0 D This stock option shall vest over 3 years, with 1/3 vesting on November 9, 2021, and thereafter in equal monthly installments over the next 24 months subject to the Reporting Person's continued service as a director through the applicable vesting date. /s/ Michel Detheux, as Attorney-in-Fact 2020-11-12